Fuat Erdem

563 total citations
44 papers, 446 citations indexed

About

Fuat Erdem is a scholar working on Oncology, Hematology and Genetics. According to data from OpenAlex, Fuat Erdem has authored 44 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Hematology and 7 papers in Genetics. Recurrent topics in Fuat Erdem's work include Chronic Myeloid Leukemia Treatments (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Fuat Erdem is often cited by papers focused on Chronic Myeloid Leukemia Treatments (4 papers), Inflammatory Biomarkers in Disease Prognosis (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). Fuat Erdem collaborates with scholars based in Türkiye and United Kingdom. Fuat Erdem's co-authors include Mehmet Ali Gündoğdu, İlhami Kıkı, Zülal Özkurt, Mehmet Parlak, Mehmet A. Taşyaran, Serpil Erol, Ahmet Kızıltunç, Refik Ali Sarı, Hasan Kaya and Murat Polat and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nephrology Dialysis Transplantation and Journal of Infection.

In The Last Decade

Fuat Erdem

41 papers receiving 412 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fuat Erdem Türkiye 12 157 91 69 68 55 44 446
Köksal Deveci Türkiye 13 65 0.4× 60 0.7× 26 0.4× 42 0.6× 67 1.2× 46 471
Marjut Kauppila Finland 11 76 0.5× 63 0.7× 12 0.2× 119 1.8× 83 1.5× 22 788
Hekim Karapınar Türkiye 13 71 0.5× 58 0.6× 22 0.3× 81 1.2× 18 0.3× 57 454
Eduardo Gutiérrez Spain 13 92 0.6× 65 0.7× 3 0.0× 137 2.0× 52 0.9× 39 754
René López Chile 8 152 1.0× 33 0.4× 16 0.2× 128 1.9× 220 4.0× 27 773
Jun Sasaki Japan 16 93 0.6× 19 0.2× 3 0.0× 154 2.3× 78 1.4× 54 723
Ángel Camarena Mexico 15 75 0.5× 80 0.9× 6 0.1× 109 1.6× 39 0.7× 30 596
Ömer Doğru Türkiye 13 54 0.3× 73 0.8× 8 0.1× 62 0.9× 20 0.4× 40 360
M. Le Bras France 13 82 0.5× 62 0.7× 3 0.0× 186 2.7× 90 1.6× 47 542
Aziz Sümer Türkiye 15 35 0.2× 20 0.2× 4 0.1× 64 0.9× 127 2.3× 63 676

Countries citing papers authored by Fuat Erdem

Since Specialization
Citations

This map shows the geographic impact of Fuat Erdem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuat Erdem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuat Erdem more than expected).

Fields of papers citing papers by Fuat Erdem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuat Erdem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuat Erdem. The network helps show where Fuat Erdem may publish in the future.

Co-authorship network of co-authors of Fuat Erdem

This figure shows the co-authorship network connecting the top 25 collaborators of Fuat Erdem. A scholar is included among the top collaborators of Fuat Erdem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuat Erdem. Fuat Erdem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erdem, Fuat, et al.. (2024). Prevalence and Prognostic Significance of Anemia in Lymphoma. Bakirkoy Tip Dergisi / Medical Journal of Bakirkoy. 20(1). 42–47. 1 indexed citations
2.
Erdem, Fuat, et al.. (2023). The Importance of Serum Procalcitonin and C-reactive Protein Levels in Patients with Lymphoma. Meandros Medical And Dental Journal. 24(2). 168–174.
3.
Erdem, Fuat, et al.. (2022). Serum Copper and Zinc Levels in Primary Immune Thrombocytopenia. Biological Trace Element Research. 200(9). 3919–3924. 4 indexed citations
4.
Erdem, Fuat, et al.. (2016). A rare cause of hyperamylasemia: multiple myeloma. Turkish Journal of Biochemistry. 41(6). 479–481. 2 indexed citations
6.
Çankaya, Erdem, et al.. (2015). SP173INCREASED NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) IS A SIGN OF DISEASE ACTIVITY IN SYSTEMIC LUPUS ERYTHEMATOSUS PATIENTS WITH RENAL INVOLVEMENT. Nephrology Dialysis Transplantation. 30(suppl_3). iii435–iii435. 1 indexed citations
8.
Erdem, Fuat, et al.. (2013). Low-dose cytosine arabinoside-induced syptomatic bradycardia in a patient with acute myeloid leukemia. Journal of Cardiology Cases. 8(3). 105–107. 2 indexed citations
9.
Yıldırım, Rahşan, et al.. (2012). Acute promyelocytic leukemia, centre, experience, Turkey. Transfusion and Apheresis Science. 48(1). 45–49. 4 indexed citations
10.
Demir, Turgut, Varol Çanakçı, Fuat Erdem, et al.. (2008). The Effects of Age and Gender on Gingival Tissue and Peripheral Blood T-Lymphocyte Subsets: A Study in Mice. Immunological Investigations. 37(2). 171–182. 4 indexed citations
11.
Kıkı, İlhami, Mehmet Ali Gündoğdu, Fuat Erdem, & Refik Ali Sarı. (2007). Atipik Klinik Prezentasyonlu Bir Temporal Arterit Olgusu. DergiPark (Istanbul University). 14(3). 207–210.
12.
Erdem, Fuat, et al.. (2007). Thrombotic Thrombocytopenic Purpura in a Patient with Brucella Infection Is Highly Responsive to Combined Plasma Infusion and Antimicrobial Therapy. Medical Principles and Practice. 16(4). 324–326. 14 indexed citations
13.
Gündoğdu, Fuat, İbrahım Pirim, Yahya İslamoğlu, et al.. (2007). Association between factor V Leiden mutation and coronary artery disease in the northeast region of Turkey. Blood Coagulation & Fibrinolysis. 18(8). 719–722. 6 indexed citations
14.
Kıkı, İlhami, Ömer Yılmaz, Fuat Erdem, et al.. (2006). Tumour necrosis factor-α levels in hepatitis B virus-related chronic active hepatitis and liver cirrhosis and its relationship to Knodell and Child-Pugh scores. International Journal of Clinical Practice. 60(9). 1075–1079. 12 indexed citations
15.
Özkurt, Zülal, İlhami Kıkı, Serpil Erol, et al.. (2005). Crimean–Congo hemorrhagic fever in Eastern Turkey: clinical features, risk factors and efficacy of ribavirin therapy. Journal of Infection. 52(3). 207–215. 153 indexed citations
16.
Aygül, Recep, et al.. (2005). Plasma Values of Oxidants and Antioxidants in Acute Brain Hemorrhage: Role of Free Radicals in the Development of Brain Injury. Biological Trace Element Research. 108(1-3). 43–52. 22 indexed citations
17.
Erdem, Fuat, Mehmet Ali Gündoğdu, İlhami Kıkı, Refik Ali Sarı, & Ahmet Kızıltunç. (2004). Vascular endothelial and basic fibroblast growth factor serum levels in patients with Behçet’s disease. Rheumatology International. 25(8). 599–603. 25 indexed citations
18.
Ertekin, Mustafa Vecdi, et al.. (2004). Zinc Sulfate in the Prevention of Total-Body Irradiation-Induced Early Hematopoietic Toxicity: A Controlled Study in a Rat Model. Biological Trace Element Research. 100(1). 63–74. 12 indexed citations
19.
Tekin, Salim Başol, Fuat Erdem, & Nesrin Gürsan. (2003). Iatrogenic Kaposi 's Sarcoma.. PubMed. 20(1). 47–9. 1 indexed citations
20.
Sarı, Refik Ali, et al.. (2001). Correlation of serum levels of soluble intercellular adhesion molecule-1 with disease activity in systemic lupus erythematosus. Rheumatology International. 21(4). 149–152. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026